EIF2AK4 and acute lymphoblastic leukemia: However, as noted earlier, inhibition of GCN2 sensitizes both ALL and AML cell lines to treatment with L-asparaginase [32], thus, indicating the complexity of the anti-leukemic roles of GCN2.